down arrow

Hikal

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE475B01022
  • NSEID: HIKAL
  • BSEID: 524735
INR
419.00
35.95 (9.39%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 5.81 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

389.30431.35

52 Week

268.05464.50
Valuation
Technical
Day's Volume

CASH

5.81 lacs (103.20%) Volume

Shareholding (Dec 2024)

FII

6.06%

Held by 79 FIIs

DII

3.48%

Held by 4 DIIs

Promoter

68.85%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate -3.32% of over the last 5 years

 
2

Flat results in Dec 24

3

Stock is technically in a Bullish range

4

With ROCE of 8.6, it has a Expensive valuation with a 2.8 Enterprise value to Capital Employed

5

Falling Participation by Institutional Investors

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 5,166 Cr (Small Cap)

stock-summary
P/E

63.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.31%

stock-summary
Debt Equity

0.61

stock-summary
Return on Equity

6.10%

stock-summary
Price to Book

3.92

Revenue and Profits (1 Year):
Net Sales:
448 Cr
(Quarterly Results - Dec 2024)
Net Profit:
17 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.31%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
23.25%
0.17%
23.42%
1 Year
38.65%
0.40%
39.05%
2 Years
40.58%
0.80%
41.38%
3 Years
-4.73%
0.90%
-3.83%
4 Years
142.34%
1.62%
143.96%
5 Years
347.65%
5.79%
353.44%

Latest dividend: 0.6 per share ex-dividend date: Feb-07-2025

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
2.97%
EBIT Growth (5y)
-3.32%
EBIT to Interest (avg)
4.37
Debt to EBITDA (avg)
2.42
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.05
Tax Ratio
27.53%
Dividend Payout Ratio
21.26%
Pledged Shares
0
Institutional Holding
9.54%
ROCE (avg)
11.77%
ROE (avg)
10.04%
Valuation key factors
Factor
Value
P/E Ratio
63
Industry P/E
33
Price to Book Value
3.92
EV to EBIT
32.05
EV to EBITDA
18.24
EV to Capital Employed
2.81
EV to Sales
3.00
PEG Ratio
15.60
Dividend Yield
0.31%
ROCE (Latest)
8.61%
ROE (Latest)
6.10%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 6 Schemes (2.92%)

FIIs

Held by 79 FIIs (6.06%)

Promoter with highest holding

Kalyani Investment Company Limited (31.36%)

Highest Public shareholder

Tata Mutual Fund - Tata Small Cap Fund (2.68%)

Individual Investors Holdings

16.64%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -1.15% vs 11.33% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -6.01% vs 258.82% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "447.70",
          "val2": "452.90",
          "chgp": "-1.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "72.10",
          "val2": "74.90",
          "chgp": "-3.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "18.70",
          "val2": "18.80",
          "chgp": "-0.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "17.20",
          "val2": "18.30",
          "chgp": "-6.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.43%",
          "val2": "16.61%",
          "chgp": "-0.18%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 4.47% vs -12.22% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 20.06% vs 21.96% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "859.70",
          "val2": "822.93",
          "chgp": "4.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "132.90",
          "val2": "107.81",
          "chgp": "23.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "38.60",
          "val2": "26.87",
          "chgp": "43.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "23.40",
          "val2": "19.49",
          "chgp": "20.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.55%",
          "val2": "13.19%",
          "chgp": "2.36%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 2.91% vs -14.03% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 14.08% vs -16.04% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,307.40",
          "val2": "1,270.43",
          "chgp": "2.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "205.00",
          "val2": "172.51",
          "chgp": "18.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "57.30",
          "val2": "41.07",
          "chgp": "39.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "40.60",
          "val2": "35.59",
          "chgp": "14.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.68%",
          "val2": "13.58%",
          "chgp": "2.10%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -11.79% vs 4.13% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -11.21% vs -51.16% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,784.60",
          "val2": "2,023.03",
          "chgp": "-11.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "267.00",
          "val2": "257.07",
          "chgp": "3.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "56.40",
          "val2": "48.10",
          "chgp": "17.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "69.60",
          "val2": "78.39",
          "chgp": "-11.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.10%",
          "val2": "12.82%",
          "chgp": "2.28%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
447.70
452.90
-1.15%
Operating Profit (PBDIT) excl Other Income
72.10
74.90
-3.74%
Interest
18.70
18.80
-0.53%
Exceptional Items
0.00
0.00
Consolidate Net Profit
17.20
18.30
-6.01%
Operating Profit Margin (Excl OI)
16.43%
16.61%
-0.18%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -1.15% vs 11.33% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -6.01% vs 258.82% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
859.70
822.93
4.47%
Operating Profit (PBDIT) excl Other Income
132.90
107.81
23.27%
Interest
38.60
26.87
43.65%
Exceptional Items
0.00
0.00
Consolidate Net Profit
23.40
19.49
20.06%
Operating Profit Margin (Excl OI)
15.55%
13.19%
2.36%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 4.47% vs -12.22% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 20.06% vs 21.96% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,307.40
1,270.43
2.91%
Operating Profit (PBDIT) excl Other Income
205.00
172.51
18.83%
Interest
57.30
41.07
39.52%
Exceptional Items
0.00
0.00
Consolidate Net Profit
40.60
35.59
14.08%
Operating Profit Margin (Excl OI)
15.68%
13.58%
2.10%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 2.91% vs -14.03% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 14.08% vs -16.04% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,784.60
2,023.03
-11.79%
Operating Profit (PBDIT) excl Other Income
267.00
257.07
3.86%
Interest
56.40
48.10
17.26%
Exceptional Items
0.00
0.00
Consolidate Net Profit
69.60
78.39
-11.21%
Operating Profit Margin (Excl OI)
15.10%
12.82%
2.28%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -11.79% vs 4.13% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -11.21% vs -51.16% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Hikal Ltd stock-summary
stock-summary
Hikal Ltd
Small Cap
Pharmaceuticals & Drugs
Hikal Limited, incorporated on July 08th, 1988, has emerged as one of the preferred partners for global companies in segments such as pharmaceuticals, crop protection, animal health, biocides, and specialty chemicals. The Company is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. Presently, it is operating in the crop protection and pharmaceuticals space.
Company Coordinates stock-summary
Company Details
717/718 Maker Chamber V, 7th Floor Nariman Point Mumbai Maharashtra : 400021
stock-summary
Tel: 91-022-3926 7100/62770477
stock-summary
http://www.hikal.com
stock-summary
secretarial@hikal.com/info@hikal.co
Registrar Details
Mondkar Computers Pvt Ltd , 21 Shakil Niwas , Opp. Satya Saibaba Temple, Mahakali Caves Road, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."